Paper397408
Complement activation in pneumonia.
Nydegger U and 4 others. Med Microbiol Immunol, 1979. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Complement activation in pneumonia. Papers, record 397408. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/397408
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement Activation | Major topic |
| Pneumonia | Major topic |
| Acute Disease | |
| Adolescent | |
| Adult | |
| Bronchopneumonia | |
| Complement System Proteins | |
| Convalescence | |
| Female | |
| Humans | |
| Klebsiella Infections | |
| Klebsiella pneumoniae | |
| Male | |
| Middle Aged | |
| Pneumonia, Mycoplasma | |
| Pneumonia, Pneumococcal | |
| Psittacosis |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,468,198 | C3 proactivator (C3PA) as an acute phase reactant. | Clin Exp Immunol | 1974 | https://conductscience.org/library/papers/4468198 | PubMed |
| 2 | 5,421,075 | Detection of endotoxin in human blood and demonstration of an inhibitor. | J Lab Clin Med | 1970 | https://conductscience.org/library/papers/5421075 | PubMed |
| 3 | 429,556 | Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions. | J Clin Invest | 1979 | https://conductscience.org/library/papers/429556 | PubMed |
| 4 | 758,005 | Complement and host defense against infection. | J Pediatr | 1977 | https://conductscience.org/library/papers/758005 | PubMed |
| 5 | 20,405 | Complement levels in pneumococcal pneumonia. | Infect Immun | 1977 | https://conductscience.org/library/papers/20405 | PubMed |
| 6 | 14,000,519 | Effect of mercaptoethanol on complement binding ability of human 7 S gammaglobulin. | Proc Soc Exp Biol Med | 1963 | https://conductscience.org/library/papers/14000519 | PubMed |
| 7 | 4,204,416 | Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level. | Clin Immunol Immunopathol | 1973 | https://conductscience.org/library/papers/4204416 | PubMed |
| 8 | 1,279,001 | Complement system in pneumococcal infections. | Infect Immun | 1976 | https://conductscience.org/library/papers/1279001 | PubMed |
| 9 | 2,634 | The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. | J Immunol | 1976 | https://conductscience.org/library/papers/2634 | PubMed |
| 10 | 4,830,223 | Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. | J Clin Invest | 1974 | https://conductscience.org/library/papers/4830223 | PubMed |
| 11 | 4,672,578 | A simple automated method for complement estimation in a continuous flow system. | J Immunol | 1972 | https://conductscience.org/library/papers/4672578 | PubMed |
| 12 | 1,245,740 | Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. | J Immunol | 1976 | https://conductscience.org/library/papers/1245740 | PubMed |
| 13 | 7,360,115 | The physiological breakdown of the third component of human complement. | Mol Immunol | 1980 | https://conductscience.org/library/papers/7360115 | PubMed |
| 14 | 4,591,850 | Phagocytosis (first of three parts). | N Engl J Med | 1974 | https://conductscience.org/library/papers/4591850 | PubMed |
| 15 | 4,114,930 | The complement system of man. I. | N Engl J Med | 1972 | https://conductscience.org/library/papers/4114930 | PubMed |
| 16 | 47,148 | Activation of the properdin pathway of complement in patients with gram-negative bacteremia. | N Engl J Med | 1975 | https://conductscience.org/library/papers/47148 | PubMed |
| 17 | 1,141,431 | Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis. | J Clin Invest | 1975 | https://conductscience.org/library/papers/1141431 | PubMed |
| 18 | 4,098,878 | Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. | Immunology | 1970 | https://conductscience.org/library/papers/4098878 | PubMed |
| 19 | 4,871,687 | Complement in human disease. | Annu Rev Med | 1968 | https://conductscience.org/library/papers/4871687 | PubMed |
| 20 | 808,993 | Inhibition of complement-derived enzymes. | Ann N Y Acad Sci | 1975 | https://conductscience.org/library/papers/808993 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,514,567 | Anti-Complement, Anti-Oxidative, and Anti-Inflammatory Activities of the Ethanol Extract of Tamarix chinensis Lour. | Plants (Basel) | 2026 | https://conductscience.org/library/papers/42514567 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/397408
GET https://conductscience.org/api/papers/v1/397408/references?page=2